The prognostic value of IDO expression in solid tumors: a systematic review and meta-analysis
出版年份 2020 全文链接
标题
The prognostic value of IDO expression in solid tumors: a systematic review and meta-analysis
作者
关键词
-
出版物
BMC CANCER
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-26
DOI
10.1186/s12885-020-06956-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Indoleamine 2,3-dioxygenase 1 and Programmed Cell Death-ligand 1 Co-expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy
- (2019) Sha Zhou et al. Cancers
- High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy
- (2019) Devarati Mitra et al. ONCOLOGIST
- Prognostic value of tumour-infiltrating CD8+ lymphocytes in rectal cancer after neoadjuvant chemoradiation: is indoleamine-2,3-dioxygenase (IDO1) a friend or foe?
- (2019) Julia Schollbach et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes
- (2019) Tamkin Ahmadzada et al. LUNG CANCER
- Indoleamine-2,3-dioxygenase-1 expression predicts poorer survival and up-regulates ZEB2 expression in human early stage bladder cancer
- (2019) Yuh-Shyan Tsai et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer
- (2018) Yuki Kiyozumi et al. ANNALS OF SURGERY
- The Impact of Indoleamine 2,3-dioxygenase (IDO) Expression on Stage III Gastric Cancer
- (2018) MASAAKI NISHI et al. ANTICANCER RESEARCH
- Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer
- (2018) Wen-Juan Ma et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma
- (2018) Yu-Feng Wei et al. LUNG CANCER
- High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer
- (2018) Hiroto Takeya et al. PATHOLOGY INTERNATIONAL
- Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
- (2017) Daniel E. Carvajal-Hausdorf et al. Journal for ImmunoTherapy of Cancer
- Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma
- (2016) Ahlem Ben-Haj-Ayed et al. IMMUNOLOGY LETTERS
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
- (2016) David H. Munn et al. TRENDS IN IMMUNOLOGY
- Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma
- (2016) Hao Liu et al. Scientific Reports
- Research progress of indoleamine 2,3-dioxygenase inhibitors
- (2015) Tianze Jiang et al. Future Medicinal Chemistry
- Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients
- (2015) Yunlong Jia et al. INTERNATIONAL JOURNAL OF CANCER
- The prognostic significance of indoleamine-2,3-dioxygenase and the receptors for transforming growth factor β and interferon γ in metastatic lymph nodes in malignant melanoma
- (2015) Maciej J. Pelak et al. POLISH JOURNAL OF PATHOLOGY
- Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
- (2015) Michael Platten et al. Frontiers in Immunology
- Aryl Hydrocarbon Receptor and Kynurenine: Recent Advances in Autoimmune Disease Research
- (2014) Nam Trung Nguyen et al. Frontiers in Immunology
- The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy
- (2012) D. Bubnoff et al. ALLERGY
- Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma
- (2012) Renske A. de Jong et al. GYNECOLOGIC ONCOLOGY
- Indoleamine 2,3 dioxygenase and metabolic control of immune responses
- (2012) David H. Munn et al. TRENDS IN IMMUNOLOGY
- Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma
- (2012) Jin Ye et al. VIRCHOWS ARCHIV
- Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients
- (2011) Reinhart Speeckaert et al. EUROPEAN JOURNAL OF CANCER
- Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests
- (2011) Jacek J. Sznurkowski et al. GYNECOLOGIC ONCOLOGY
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy
- (2010) Tomoko Inaba et al. GYNECOLOGIC ONCOLOGY
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
- Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma
- (2009) Hiroshi Urakawa et al. CLINICAL & EXPERIMENTAL METASTASIS
- Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
- (2009) X. Liu et al. CURRENT CANCER DRUG TARGETS
- Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival
- (2008) K. Ino et al. CLINICAL CANCER RESEARCH
- Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway
- (2008) Helen J. Ball et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma
- (2008) Ke Pan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started